FDA Releases Draft Guidance Outlining Principles of Drug/Diagnostic Codevelopment

The US Food and Drug Administration released a draft guidance on the principles of drug and diagnostic codevelopment as a practical framework for sponsors advancing a therapeutic alongside a companion test and for agency staff reviewing these products. “Codevelopment of IVD companion diagnostics and therapeutic products is critical to the advancement of precision medicine,” the agency stated in the draft guidance.